ebook Munafa Stock Market Course + Intraday & FNO calls  

       

506235 announcements Alembic Ltd. announcements and dividends declared BSE

Alembic Ltd. Complete list of announcements declared & dividend announcements by Alembic Ltd. 506235

Alembic Ltd. 506235 listed on BSE and deals in

Announcements and dividends declared by Alembic Ltd. 506235

Alembic Pharma Q3 Results: Company posts 23% YoY decline in net profit at Rs 138 crore, revenue up 4%
Drug maker Alembic Pharma on Monday reported Rs 138 crore net profit in Q3FY25, which is 23% year-on-year (YoY) decline compared to corresponding period of previous year, led by lacklustre growth in India business due to headwinds in the acute segment, des
Announcement as on 03 February 2025

Alembic Pharmaceuticals gets USFDA nod for generic antidepressant tablets
Alembic Pharmaceuticals has received final approval from the USFDA for its generic version of Brexpiprazole tablets, used in treating major depressive disorder and schizophrenia. The approval covers strengths from 0.25 mg to 4 mg, and the market size for t
Announcement as on 15 January 2025

Alembic Pharmaceuticals gets USFDA nod for generic hypertension treatment capsules
Alembic Pharmaceuticals Ltd has secured final approval from the USFDA for its generic Diltiazem Hydrochloride extended-release capsules. These capsules, available in strengths of 120 mg to 360 mg, are designed to treat hypertension and manage angina. This
Announcement as on 11 November 2024

Alembic Pharma Q2 Results: Net profit rises 12% to Rs 153 crore, revenue up 3%
Alembic Pharma reported a 12% YoY rise in Q2FY25 net profit to Rs 153 crore, driven by strong domestic and US market sales. Revenues grew 3% to Rs 1648 crore, while EBITDA declined 6%, with margins at 15.6%
Announcement as on 07 November 2024

Alembic Pharma gets USFDA nod for generic hypertension treatment capsules
Alembic Pharmaceuticals has received USFDA final approval for its generic Diltiazem Hydrochloride extended-release capsules in strengths of 120 mg, 180 mg, and 240 mg to treat hypertension and chronic stable angina. These capsules are therapeutically equiv
Announcement as on 21 October 2024

Announcements by Alembic Ltd. first page | Next page | Prev page |

506235 Alembic Ltd. current price & indicator signals

Moving Averages for Alembic Ltd.

  • 5Day Average: 87.61
  • 12Day Average: 89.22
  • 20Day Average: 90.69
  • 50Day Average: 86.38
  • 100Day Average: 90.67
  • 150Day Average: 93.87
  • 200Day Average: 96.64

506235 Indicators & signals

Indicator MACD (12,26,9)

89.03, 89.29, 0.44
Indicator MACD is in negative zone

Indicator ADX (14)

11.54, 19.09, 24.07
Indicator ADX is indicating that momentum is weak.
Momentum is towards selling.

Indicator RSI (14)

Current RSI is: 49
Indicator RSI is indicating buying momentum and stock might rise.

Recent prices of 506235 Alembic Ltd. are as follows: Daily volume is divided by 10 day averaged volume

Date Close Range Change % Volume
26 Tue May 2026 88.01 87.65 to 88.88 0.32% 1.26 times
25 Mon May 2026 87.73 87.13 to 89.40 0.31% 1.1 times
22 Fri May 2026 87.46 87.11 to 88.85 0.09% 0.78 times
21 Thu May 2026 87.38 87.00 to 89.20 -0.13% 0.87 times
20 Wed May 2026 87.49 86.80 to 88.51 -2.75% 0.82 times
19 Tue May 2026 89.96 88.00 to 91.00 1.67% 1.31 times
18 Mon May 2026 88.48 86.88 to 90.38 -1.49% 0.66 times
15 Fri May 2026 89.82 89.70 to 92.00 -1.75% 1.05 times
14 Thu May 2026 91.42 90.00 to 91.74 1.6% 0.76 times
13 Wed May 2026 89.98 89.06 to 90.70 -0.48% 1.23 times
12 Tue May 2026 90.41 90.05 to 92.84 -2.28% 1.42 times
11 Mon May 2026 92.52 92.00 to 93.93 -2.55% 2.29 times

Videos related to: 506235 announcements Alembic Ltd. announcements and dividends declared BSE

Hindi Video Correct Way Of Fundamental Analysis Using EPS And PE - MunafaSutra

Hindi Video What Is Needed To Succeed In Stock Markets

506235 announcements Alembic Ltd. announcements and dividends declared BSE

 

Back to top